BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21517897)

  • 1. Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5·0, a novel, automatic interface-controlled apheresis system: results from the first feasibility trial.
    Brauninger S; Bialleck H; Thorausch K; Seifried E; Bonig H
    Vox Sang; 2011 Oct; 101(3):237-46. PubMed ID: 21517897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic donor peripheral blood "stem cell" apheresis: prospective comparison of two apheresis systems.
    Brauninger S; Bialleck H; Thorausch K; Felt T; Seifried E; Bonig H
    Transfusion; 2012 May; 52(5):1137-45. PubMed ID: 22044384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatic interface-controlled apheresis collection of stem/progenitor cells: results from an autologous donor validation trial of a novel stem cell apheresis device.
    Reinhardt P; Brauninger S; Bialleck H; Thorausch K; Smith R; Schrezenmeier H; Seifried E; Wiesneth M; Bonig H
    Transfusion; 2011 Jun; 51(6):1321-30. PubMed ID: 21155834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Spectra Optia apheresis system for mononuclear cell (MNC) collection in G-CSF mobilized and nonmobilized healthy donors: results of a multicenter study.
    Karafin MS; Graminske S; Erickson P; Walters MC; Scott EP; Carter S; Padmanabhan A
    J Clin Apher; 2014 Oct; 29(5):273-80. PubMed ID: 24677347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single center comparison between three different apheresis systems for autologous and allogeneic stem cell collections.
    Flommersfeld S; Bakchoul T; Bein G; Wachtel A; Loechelt C; Sachs UJ
    Transfus Apher Sci; 2013 Dec; 49(3):428-33. PubMed ID: 23827328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective comparison between COBE SPECTRA and SPECTRA OPTIA apheresis systems for hematopoietic progenitor cells collection for autologous and allogeneic transplantation in a single center.
    López-Pereira P; Sola Aparicio E; Vicuña Andrés I; Cámara Montejano C; Muñoz Calleja C; Alegre Amor A; Aguado Bueno B
    J Clin Apher; 2020 Sep; 35(5):453-459. PubMed ID: 32798328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte collection using a novel apheresis system eases the procedure and provides concentrates of high quality.
    Leitner GC; Kolovratova V; Horvath M; Worel N
    Transfusion; 2015 May; 55(5):991-5. PubMed ID: 25412946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobilization and collection of allogeneic peripheral blood progenitor cells for transplantation.
    Wiesneth M; Schreiner T; Friedrich W; Bunjes D; Duncker C; Krug E; Maccari B; Müller S; Nowak S; Kubanek B
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S21-4. PubMed ID: 9712487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte collections: comparison of two apheresis systems.
    Thorausch K; Schulz M; Bialleck H; Luxembourg B; Seifried E; Bonig H
    Transfusion; 2013 Dec; 53(12):3262-8. PubMed ID: 23581500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation.
    Sautois B; Baudoux E; Salmon JP; Michaux S; Schaaf-Lafontaine N; Pereira M; Paulus JM; Fillet G; Beguin Y
    Haematologica; 2001 Nov; 86(11):1209-18. PubMed ID: 11694408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collection of peripheral blood progenitor cells on Day 4 is feasible and effective while reducing granulocyte-colony-stimulating factor exposure to healthy donors.
    Flommersfeld S; Sohlbach K; Jaques G; Bein G; Hoffmann J; Kostrewa P; Sachs UJ
    Transfusion; 2015 Jun; 55(6):1269-74. PubMed ID: 25647638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric apheresis with a novel apheresis device with electronic interface control.
    Sörensen J; Jarisch A; Smorta C; Köhl U; Bader P; Seifried E; Bönig H
    Transfusion; 2013 Apr; 53(4):761-5. PubMed ID: 22882156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collection of hematopoietic CD34 stem cells in rhesus macaques using Spectra Optia.
    Haynes LD; Coonen J; Post J; Brunner K; Bloom D; Hematti P; Kaufman DB
    J Clin Apher; 2017 Oct; 32(5):288-294. PubMed ID: 27578423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous CD34+ cell collection by a new device is safe and more efficient than by a standard collection procedure: results of a two-center, crossover, randomized trial.
    Cancelas JA; Scott EP; Bill JR
    Transfusion; 2016 Nov; 56(11):2824-2832. PubMed ID: 27589225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the new continuous mononuclear cell collection protocol versus an older version on two different apheresis machines.
    Spoerl S; Wäscher D; Nagel S; Peschel C; Verbeek M; Götze K; Krackhardt AM
    Transfusion; 2018 Jul; 58(7):1772-1780. PubMed ID: 29732573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors.
    Martínez C; Urbano-Ispizua A; Marín P; Merino A; Rovira M; Carreras E; Montserrat E
    Bone Marrow Transplant; 1999 Dec; 24(12):1273-8. PubMed ID: 10627634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients.
    Long G; Waller EK; Gregurek S; Tricot G; Marschner S; Bill J
    J Clin Apher; 2015 Feb; 30(1):1-7. PubMed ID: 24941931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectra Optia granulocyte apheresis collections result in higher collection efficiency of viable, functional neutrophils in a randomized, crossover, multicenter trial.
    Cancelas JA; Padmanabhan A; Le T; Ambruso DR; Rugg N; Worsham DN; Pinkard SL; Graminske S; Buck J; Goldberg J; Bill J
    Transfusion; 2015 Apr; 55(4):748-55. PubMed ID: 25382805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.